Study design. Historical, register-based cohort study following 85 patients in the course of a time frame extending from 2 years before to 2 years after trauma occurrence. Objective. To investigate the cost-effectiveness of surgery versus conservative management for thoracolumbar burst fractures. Summary of background data. Despite the prevalence of thoracolumbar burst fractures, consensus has still not been reached in terms of their clinical management and whereas from a health policy point of view, efficient use of resources is equally important, literature pertaining to this aspect is limited. Methods. Consecutive patients who were admitted to a university clinic between 2004 and 2008 because of CT-verified AO type A3 fractures (T11-L2), age 18 to 65 years Patients with neurological compromise, osteoporosis, or malignancy were not included. The cost parameter defined primary and secondary health-care use (2010 s) and the effect parameter was based on three alternative measures of pain medication: morphine milligram and defined daily doses (DDD) of narcotic and nonnarcotic analgesics. For cost-effectiveness analysis, we employed a difference-in-difference approach, including control for treatment selection (age, sex, and fracture type). Nonparametric bootstrapping was used to estimate conventional 95% confidence intervals of mean estimates. Results. When taking into consideration all health-care consumption, surgical management was observed to cost an additional s10,734 (4215; 15,144) as compared with conservative management. The differences on morphine at 527(-3031; 6,016) milligram, narcotic analgesics at -8(-176; 127) DDD, and nonnarcotic analgesics at -3(-72; 58) DDD were all insignificant The probability for surgery being cost-effective did not exceed 50% for any value of willingness to pay for effect. Conclusion. Surgical management does not seem to be a costeffective strategy as compared with conservative management for traumatic thoracolumbar burst fractures without neurological deficits. In addition, higher-volume studies examining the clinical effect of alternative management strategies would be valuable.
B
urst fractures of the spine occur under substantial axial forces, which lead to failure of the anterior and middle columns. 1 Approximately 50% of patients with burst fractures do not experience neurological compromise;
1,2 incidence rates among spine fractures were reported to be between 15% to 20%. 3, 4 Treatment options may vary from conservative to surgical interventions. [5] [6] [7] [8] However, management of a nonneurologically compromised group remains unclear.
Several studies investigated management options of thoracolumbar burst fractures, 5, 6, [8] [9] [10] nevertheless level one evidence is still limited. 11 The reason for this scarcity is to some extent caused by the nature of the research context, which limits the possibility to conduct experimental trials. 12 The difficulty of administering questionnaires and obtaining informed consents from patients who are experiencing the initial phase of trauma constitutes a natural barrier. Thus, there is a necessity for employing observational studies as a second-best approach to informing clinical guidelines.
Thoracolumbar injury studies of the associated healtheconomic consequences are limited and include methodological such shortcomings as heterogenity of patient populations and a weak analytical approach, which constitute a potential problem in terms of drawing any conclusions. 13, 14 According to the literature, the incidence of vertebral column or spinal cord injuries is lower but costs per patient are higher as compared with other types of injuries. 15 From a health policy management point of view, the interesting issue is whether one or the other management strategy is more cost-effective, given that alternatives seem equally effective from a clinical point of view.
The aim of the current study was to investigate the costeffectiveness of surgical versus conservative management of thoracolumbar burst fractures.
MATERIALS AND METHODS

Study Design and Materials
The study was conducted as a historical, register-based cohort study following 85 patients from 2 years before to 2 years after trauma. Consecutive patients, who were admitted to our university hospitals' orthopedics and neurosurgery departments during the period of January 1, 2004 to December 31, 2008, were included. The hospital's electronic registry system was used to locate patients with the relevant diagnostic codes, fracture level, trauma date and etiology, treatment details, and neurological status. We included patients with (1) CT-verified AO type A3 fractures (T11-L2) and (2) age between 18 and 65 years. Patients with neurological compromise and fractures secondary to osteoporosis/malignancy were excluded.
Treatment
Conservative management consisted of bracing for 12 weeks; compliance was not monitored. There were no patients who needed surgery for aggravation of symptoms during the conservative treatment period. Surgery consisted of posterior pedicle screw fixation with or without fusion according to operating departments' preference. Only two patients underwent implant removal surgery because of surgeons' preference, and one patient was reoperated because of deep wound infection.
Cost-Effectiveness Analysis
The analysis was conducted from a health care sector perspective. Resource use in the primary and secondary health care sectors was examined in a time frame of 2 years before and 2 years after trauma. Various national registries were combined using the unique civil registry number of individuals. All costs were converted into euros (s) and inflated to the common price year 2010 using the consumer price index.
Primary Health Care
Five main categories, that is, General Practitioners (GPs), Medical Specialists, Physiotherapists/Chiropractors, Dentists, and Others, were extracted and defined using The National Health Insurance Service Registry (NHISR). Activity-based tariffs that are negotiated biannually between the NHISR and the professional societies of medical specialists or therapists were used for valuation. 16 
Secondary Health Care
Data pertaining to hospital-based health care, including admissions, outpatient, and emergency room visits were obtained via the National Patient Registry (NPR). 16, 17 The NPR includes information about diagnostic and procedure codes, bed-days, and diagnosis-related-grouping (DRG) tariffs. 18 These tariffs represent national average costs and they were made used to value the hospital-based service use.
Effect Measures
Three alternative effect measures, all representing pain medication, were used. These were based on the National Registry for Prescription Medication, which includes all prescriptions prescribed to individual persons. First, the oral morphine equivalent (OME) was defined in milligrams and adopted as the primary effect measure. Second, the defined daily doses (DDD) of narcotic and nonnarcotic analgesic, respectively, were used as secondary effect parameters.
Statistical Analysis
In descriptive tables, conventional summary statistics were used. Confidence intervals (CI) for costs and effect parameters were calculated by using 5000 bias corrected bootstrapped replicates.
A difference-in-difference estimator was defined and based on the difference between the period differences (the period 2 years after versus the period 2 years before trauma) of surgical and conservative management, respectively. Multiple linear regression was used to estimate this estimator, 19 whereas at the same time adjusting for selection based on age, sex, and sub-classification of AO type A3 fractures. Identical models were used for costs and effect differences, respectively:
Where DC and DE refer to the cost difference and the effect difference, respectively, between the periods before and after trauma, conservative is a dummy for treatment, age refers to age groups (18-35 yrs,35-50 yrs, and 50-65 yrs), male is a dummy for sex, and incomplete burst is a dummy for AO type 3 classification for the individual patient i. Regression diagnostics were used to assess model validity and unadjusted values were additionally estimated to support transparency of methods. In regression diagnostics residuals versus fitted values, residuals versus possible determinants, the normality of residuals were investigated.
Mean differences were estimated along with 95% CI based on nonparametric bootstrapping (5000 replications) because of the skewed nature of the data. The precision of estimates was furthermore illustrated in conventional costeffectiveness planes. Finally, costs and effect differences were transformed into net benefits to illustrate cost-effectiveness acceptability curves. 20 These curves show the overall probability that surgical management is more costeffective than conservative management.
Ethics
Permission to collect data was granted by the Danish Data Protection Agency (2011-41-6984). Table 1 shows baseline characteristics of patients managed with either surgery or conservative treatment (n ¼ 85). The conservative and surgery group were well matched for all variables except fracture etiology.
RESULTS
Baseline Characteristics
Costs and Resource Use
The observed resource use and associated costs are shown in Tables 2 and 3 . The costs attributable to trauma were s7841(3654; 12,361) for conservative management and s21,266 (11,440; 31,586) for surgical management. The surgical group showed a tendency towards higher use of primary health care, which was approximately three-fold that of the conservative group. In relation to secondary health care, hospital inpatient costs were statistically higher for the surgery group with s18,813 (10,292; 26,100).
Effect as Pain Medication Use
Narcotics use before trauma was much higher than anticipated for both of the groups (Table 4) . Further detailed revisits revealed two chronic narcotic users, one in each treatment group. Nevertheless, we analyzed the differences in which intrapersonal variability cancelled out and delta values showed similarity.
Cost-Effectiveness
The crude and adjusted incremental costs and effects are shown in Table 5 . The incremental cost of surgery was estimated as s10,734(4215; 15,144). We did not observe any statistical significance for incremental effect parameters. After regression model diagnostics, two potential outliers, one for each treatment group, were identified. The first patient suffered from severe chronic disease before trauma and died in approximately 1 year. The second patient suffered from head injury shortly after trauma and was hospitalized for a lengthy period. Figure 1A , B illustrates the bootstrapped replications of incremental costs and effects between groups. Two different aspects of pain medication consumption were applied to clarify both the narcotic and nonnarcotic analgesic use (DDD-concept and actual oral morphine equivalent dose in milligrams). The replications of Incremental Cost-Effectiveness Ratio estimates indicated that surgery is equally effective but incurs higher costs, as the majority of the circles were located in the northern part of the y-axis and evenly distributed to both the northwest (NW) and northeast (NE) quadrants. In Figure 1A , projection of replicates showed that approximately two-thirds of the blue and red circles were located in the NW quadrant of the plane. In Figure 1B , analysis with DDD values of narcotic and nonnarcotic analgesics showed a similar pattern, with circles evenly distributed in the NE and NW quadrants. Figure 2 illustrates the cost-effectiveness acceptability curve, which shows the probability that surgery is more cost-effective than conservative management for a range of monetary values that a decision maker might be willing to pay (K) for a unit change in outcomes. When the treatment is more effective and more costly, the curve shows an increasing tendency to make an asymptote to 1 by increasing values of willingness-to-pay. For our study, the curves did not show this property, as surgery did not demonstrate an additional, positive effect for all patients. The curve was observed to asymptote to less than a 50% probability for cost-effectiveness for infinite values of willingness-to-pay.
DISCUSSION
This study represents the pioneering effort to analyze the synthesis of costs and effects of surgical versus conservative management of thoracolumbar burst fractures.
Previous studies have investigated the health economical aspects of thoracolumbar burst fractures. However, these studies were limited to cost descriptions or cost analyses. 6, 14 In a randomized controlled trial, Wood et al 6 reported the mean cost of surgery and conservative treatment at approximately $49,000 and $11,000. The resulting cost difference of about $38,000 is substantially higher than the present but the two estimates cannot be compared because of different cost perspectives in particular, the present estimate includes all service use including whether or not index treatment affects, for example, the use of later readmissions or primary care. Similarly, Siebenga et al 14 reported the direct costs of posterior pedicle screw instrumentation and conservative treatment at approximately s18,000 and s10,000, resulting in a far lower cost difference of the same magnitude as that of the current study, but again of an incomparable cost perspective.
In our study, we observed no statistically significant difference in outcomes between the comparators. This is in line with several previous thoracolumbar burst fracture studies where the pain-based Visual Analog Scale (VAS) scale was used for effect measurement. 6, 7, 21 Internal Validity Defining and measuring the optimal effect parameter in spine trauma is a challenging task because of both a lack of validated measurement instruments and the nature of trauma, where baseline measurements are often not possible to obtain. Roland Morris Disability Questionnaire, Oswestry Disability Index, Short Form 36, and VAS have been commonly used as outcome measurement in thoracolumbar burst fracture studies. 5, 6, 7, 22 Nevertheless, these measures have not been validated for spine trauma populations. In a review, Stadhouder et al 23 reported that present outcome measures in the spine field are not capable of capturing all relevant dimensions pertinent to spinal trauma. We introduced total analgesics use as an alternative proposal, which in many settings, can be based on register data. These data are always available and normally do not suffer from nonresponse, recall issues, and misclassification. Although we do not argue that this measure is superior to a VAS scale anchored on pain, we believe it is a pragmatic solution until new measures have been developed, as it solves the baseline measurement challenge. Finally, it should be mentioned that the relationship between pain and quality-of-life is well established. 24 The effect parameter we used also allowed us to picture subcategories that characterize different dimensions of the pain problem. Conversion to OME dose was applied to obtain a single dose related to narcotic analgesic medication, whereas calculation of DDD allowed us to estimate the duration of pain medication. 25 We were not able to measure the effect of treatment over return to work rates and working performance in this current study. Therefore, our result will be unjustified if surgery results an earlier return to work, which might change the overall costs from a societal perspective. However, a recent meta-analysis 21 showed that there is no difference in return to work rates between operative and nonoperative group.
The sample size of the current study was limited to 85 consecutive patients. It is relevant to emphasize the importance of the relatively small sample size of our study, which is a reflection of the trade-off between investigating a homogeneous population in terms of both patient characteristics and time trends and achieving large volume. In a metaanalysis of thoracolumbar burst fracture treatments, Gnanenthiran et al, 21 reported sample sizes of four prospective clinical trials between 31 to 83. This illustrates that limited numbers are indeed not abnormal. It should be noted that sample size is usually a matter of obtaining statistical significance rather than validity of the findings per se. In accordance with this logic, we prioritized validity over precision, but a further consequence is that we were then not allowed to adjust for that many variables in the regression-based approach used to control for selection. On the other hand, we have not been able to identify studies in the literature demonstrating the need to control for other factors than we actually did (age, sex, and fracture type).
Strengths and Limitations
We employed a difference-in-difference approach, as it allowed us to control for intrapersonal variability as well as time trends. When it is additionally supplemented with control for selection, we argue that it is probably the strongest research design in cases where it is difficult to conduct randomized controlled trials. The second major strength is that we utilized national registries, which include all activities without any missing values.
There are several limitations. Firstly, we cannot argue that selection bias has been completely eliminated by adjusting for only age, sex, and fracture type. It would be valuable for future studies in larger populations to examine whether or not additional covariates should be adjusted for. Acceptability curves illustrating the probability that surgery is cost-effective over conservative treatment based on pain parameters. For given values of decision makers, maximum willingness-to-pay (the ceiling ratio at the x-axis) and the probability of cost-effectiveness (y-axis) can be read from the curves for both unadjusted and adjusted values.
Secondly, a broader cost perspective might change the overall difference between comparators, for example, because of management strategies affecting work and social performance. Thirdly, a broader effect measure such as healthrelated quality-of-life (HRQL) gain resulting from the selected treatment could provide a better reflection of management strategy outcome. Finally, a review of surgeons' choice on treatment decision could enhance our understanding of our results.
CONCLUSION
Our study showed that conservative management appeared to be a better choice in terms of cost-effectiveness for traumatic thoracolumbar burst fractures without neurological deficits from a health care sector perspective. However, a possible cost-effectiveness difference from a societal perspective will eventually be dependent on the time to return to work. Further, health-economical research in tandem with a randomized clinical trial or from multicentral registers including HRQL instruments together with production loss expenses might help us to improve the evaluation of current management approaches and decision making of these fractures.
